AGNPF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Algernon Pharmaceuticals (AGNPF) Ownership - Who owns Algernon Pharmaceuticals?

Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis, and chronic cough... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

601 West Broadway

Phone

+1 604 398-4175

Employees

N/A

Web

https://www.algernonpharmaceuticals.com

Details

Group

Domestic Stock Funds

Fundamentals

AGNPF

Capitalization

1.66M

P/E Ratio

N/A

Risk (Beta)

0.98

Dividend Yield

N/A

Total Cash

358K

Total Cash/Share

0.01

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

1.79M

P/B Ratio

1.27

Cash Flow

N/A

Earnings

-0.01

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

29.6M

Current Ratio

0.23

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-2.25M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-9.53

Shares Held By Institutions

Shares Outstanding - Current

27.3M

Total Liabilities

1.87M

Total Volume MTD

N/A

Value

Gain YTD

29.590

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology